We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.47%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.94B
AUM Growth
+$184M
Cap. Flow
-$79.5M
Cap. Flow %
-2.7%
Top 10 Hldgs %
42.7%
Holding
135
New
34
Increased
27
Reduced
33
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Consumer Staples 11.86%
3 Consumer Discretionary 11.13%
4 Technology 1.98%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WYNN icon
76
Wynn Resorts
WYNN
$10.5B
$6.77M 0.23%
60,000
-24,000
-29% -$2.21M
NEPT
77
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$6.5M 0.22%
+2,976
New +$7.65M
PLAN
78
DELISTED
Anaplan, Inc.
PLAN
$6.04M 0.21%
84,000
-4,000
-5% -$260K
ADBE icon
79
Adobe
ADBE
$103B
$6M 0.2%
+12,000
New +$5.8M
DT icon
80
Dynatrace
DT
$14.2B
$5.88M 0.2%
+136,000
New +$5.4M
SMAR
81
DELISTED
Smartsheet Inc.
SMAR
$5.68M 0.19%
82,000
-18,000
-18% -$1.06M
CRWD icon
82
CrowdStrike
CRWD
$211B
$5.3M 0.18%
+100,000
New +$3.9M
RNAC icon
83
Cartesian Therapeutics
RNAC
$257M
$4.96M 0.17%
+54,533
New +$4.73M
CRI icon
84
Carter's
CRI
$1.48B
$4.93M 0.17%
+52,404
New +$4.61M
VFC icon
85
VF Corp
VFC
$5.8B
$4.25M 0.14%
+49,781
New +$3.98M
RZLT icon
86
Rezolute
RZLT
$453M
$4M 0.14%
+333,990
New +$6.19M
TELA icon
87
TELA Bio
TELA
$38.5M
$3.85M 0.13%
256,000
+96,000
+60% +$1.56M
TENX icon
88
Tenax Therapeutics
TENX
$498M
$3.76M 0.13%
1,262
BXRX
89
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$3.54M 0.12%
+2,505
New +$5.12M
AMYT
90
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.83M 0.1%
200,000
-106,000
-35% -$1.38M
LMNL
91
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$2.37M 0.08%
+56,524
New +$3.09M
LFWD icon
92
ReWalk Robotics
LFWD
$20.8M
$1.84M 0.06%
+16,606
New +$1.76M
HIND
93
Vyome Holdings
HIND
$15M
$1.65M 0.06%
1
SYTAW
94
DELISTED
Siyata Mobile Warrant
SYTAW
$1.27M 0.04%
150,000
NERV icon
95
Minerva Neurosciences
NERV
$207M
$1.17M 0.04%
62,500
PTE
96
DELISTED
PolarityTE, Inc. Common Stock
PTE
$1.15M 0.04%
+67,569
New +$1.43M
KBNTW
97
DELISTED
Kubient, Inc. Warrant
KBNTW
$1.11M 0.04%
275,000
STAB
98
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$1.1M 0.04%
+320,053
New +$911K
MDGSW
99
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$1.09M 0.04%
1,285,715
SRGA
100
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$955K 0.03%
+14,533
New +$948K

Similar funds

Armistice Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Armistice Capital held 135 positions worth $2.94B, up 6.7% from $2.76B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Armistice Capital's Q4 2020 filing shows 34 new, 27 increased, 33 reduced and 29 closed positions. Its largest new stake was Walmart Inc: 1,110,675 shares worth $53.4M. The largest sale was Alexion Pharmaceuticals, an estimated $57.2M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q4 2020 buy was Walmart Inc: 1,110,675 shares worth $53.4M.
  • Armistice Capital added most to Biogen in Q4 2020, an estimated $40.8M increase.
  • Armistice Capital's biggest Q4 2020 reduction was Energizer, cutting an estimated $29.6M.
  • Armistice Capital fully exited Alexion Pharmaceuticals in Q4 2020, selling an estimated $57.2M.
  • Armistice Capital's ten largest holdings make up 43% of its $2.94B portfolio in Q4 2020.
  • Armistice Capital opened 34 new positions and closed 29 in Q4 2020.
  • Armistice Capital's portfolio value rose 6.7% quarter-over-quarter to $2.94B.

Based on Armistice Capital's 13F filing for Q4 2020, filed 16 Feb 2021.